Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.

Perales MA, Jenq R, Goldberg JD, Wilton AS, Lee SS, Castro-Malaspina HR, Hsu K, Papadopoulos EB, van den Brink MR, Boulad F, Kernan NA, Small TN, Wolden S, Collins NH, Chiu M, Heller G, O'Reilly RJ, Kewalramani T, Young JW, Jakubowski AA.

Bone Marrow Transplant. 2010 Sep;45(9):1408-16. doi: 10.1038/bmt.2009.371. Epub 2010 Jan 11.

2.

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ.

Biol Blood Marrow Transplant. 2010 Feb;16(2):253-62. doi: 10.1016/j.bbmt.2009.10.004. Epub 2009 Oct 12.

3.

Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia.

Serbina NV, Cherny M, Shi C, Bleau SA, Collins NH, Young JW, Pamer EG.

J Immunol. 2009 Aug 15;183(4):2678-87. doi: 10.4049/jimmunol.0803398. Epub 2009 Jul 27.

4.

Characterization of antiestrogenic activity of the Chinese herb, prunella vulgaris, using in vitro and in vivo (Mouse Xenograft) models.

Collins NH, Lessey EC, DuSell CD, McDonnell DP, Fowler L, Palomino WA, Illera MJ, Yu X, Mo B, Houwing AM, Lessey BA.

Biol Reprod. 2009 Feb;80(2):375-83. doi: 10.1095/biolreprod.107.065375. Epub 2008 Oct 15. Erratum in: Biol Reprod. 2009 Jun;80(6):1306.

5.

Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.

Castro-Malaspina H, Jabubowski AA, Papadopoulos EB, Boulad F, Young JW, Kernan NA, Perales MA, Small TN, Hsu K, Chiu M, Heller G, Collins NH, Jhanwar SC, van den Brink M, Nimer SD, O'Reilly RJ.

Biol Blood Marrow Transplant. 2008 Apr;14(4):458-68. doi: 10.1016/j.bbmt.2008.02.006.

6.

Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.

Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1313-23. Epub 2007 Sep 7.

7.

Deadly serious details.

Collins NH.

Cytotherapy. 2001;3(1):1-2. No abstract available.

PMID:
12028836
8.

Adrian P. Gee, PhD, Editor Laureate.

Collins NH.

Cytotherapy. 2001;3(5):357-9. No abstract available.

PMID:
11953014
9.

ISHAGE committees--the whole is, indeed, and in deed, greater than the sum of its parts.

Collins NH, Gee AP.

Cytotherapy. 1999;1(2):97-8. No abstract available.

PMID:
19746585
10.

Buzz, hype...foundation.

Collins NH.

J Hematother. 1998 Oct;7(5):401. No abstract available.

PMID:
9829313
11.

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW.

Blood. 1998 Feb 1;91(3):1083-90.

12.

Multinational, multicultural, and multiprofessional lessons.

Collins NH.

J Hematother. 1997 Jun;6(3):189-90. No abstract available.

PMID:
9234173
13.

Translational research and responsibility.

Collins NH.

J Hematother. 1996 Dec;5(6):597-8. No abstract available.

PMID:
9117247
14.

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, et al.

Blood. 1995 Aug 15;86(4):1261-8.

15.

Serum granulocyte colony-stimulating factor (G-CSF) levels after allogeneic T cell-depleted marrow transplantation.

Papadakis V, Diaz-Barrientos T, Heller G, Collins NH, McKeever S, Kernan NA.

Bone Marrow Transplant. 1995 Jun;15(6):955-61.

PMID:
7581097
16.

Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?

Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, O'Reilly RJ.

Bone Marrow Transplant. 1995 Apr;15(4):591-4.

PMID:
7655386
17.

Metastatic proliferation of meetings.

Collins NH.

J Hematother. 1995 Apr;4(2):71. No abstract available.

PMID:
7633843
18.

T-cell depletion and manipulation in allogeneic hematopoietic cell transplantation.

Collins NH, Fernández JM.

Immunomethods. 1994 Dec;5(3):189-96. Review.

PMID:
7780686
19.

ISHAGE grows up. International Society for Hematotherapy and Graft Engineering.

Gee AP, Collins NH.

J Hematother. 1993 Spring;2(1):1-2. No abstract available.

PMID:
7921960
20.

Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.

Gazzola MV, Collins NH, Tafuri A, Keever CA.

Exp Hematol. 1992 Feb;20(2):201-8.

PMID:
1371965
21.

New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.

Collins NH, Carabasi MH, Bleau S, Jagiello C, Young JW, Castro-Malaspina H, Flomenberg N, Papadopoulos EB, Emanuel D, Gillio A, et al.

Prog Clin Biol Res. 1992;377:427-39. No abstract available.

PMID:
1438441
22.

Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease.

Keever CA, Flomenberg N, Gazzola MV, Pekle K, Yang SY, Small TN, Collins NH, O'Reilly RJ.

Hum Immunol. 1990 Sep;29(1):42-55.

PMID:
2211189
23.

NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.

Keever CA, Pekle K, Gazzola MV, Collins NH, Gillio A.

Cell Immunol. 1990 Mar;126(1):211-26.

PMID:
1689220
24.

Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.

Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.

J Immunol. 1989 Nov 15;143(10):3241-9.

PMID:
2809200
25.
26.

Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency.

Keever CA, Flomenberg N, Brochstein J, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ.

Clin Immunol Immunopathol. 1988 Sep;48(3):261-76.

PMID:
3042210
27.

Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics.

Kernan NA, Bordignon C, Keever CA, Cunningham I, Castro-Malaspina H, Collins NH, Small TN, Brochstein J, Emanuel D, Laver J, et al.

Transplant Proc. 1987 Dec;19(6 Suppl 7):29-32. No abstract available.

PMID:
2962353
28.

The role of residual host immunity in graft failures following T-cell-depleted marrow transplants for leukemia.

Bordignon C, Kernan NA, Keever CA, Benazzi E, Small TN, Brochstein J, Cunningham I, Collins NH, Emanuel D, Laver J, et al.

Ann N Y Acad Sci. 1987;511:442-6. No abstract available.

PMID:
3326473
29.

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ.

Blood. 1986 Sep;68(3):770-3.

30.

Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay.

Kernan NA, Flomenberg N, Collins NH, O'Reilly RJ, Dupont B.

Transplantation. 1985 Sep;40(3):317-22.

PMID:
3875918
31.

Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes.

Yang SY, Morishima Y, Collins NH, Alton T, Pollack MS, Yunis EJ, Dupont B.

Immunogenetics. 1984;19(3):217-31.

PMID:
6200434
32.
33.

Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.

Morishima Y, Kobayashi M, Yang SY, Collins NH, Hoffmann MK, Dupont B.

J Immunol. 1982 Sep;129(3):1091-8.

PMID:
6980917
34.

Carbohydrate differences in human high molecular weight antigens of B- and T-cell lines.

Morishima Y, Ogata S, Collins NH, Dupont B, Lloyd KO.

Immunogenetics. 1982;15(5):529-35. No abstract available.

PMID:
6179863
35.

Immunologic interactions between parental and reciprocal F1 hybrid rats.

Collins NH, Silvers WK.

Transplant Proc. 1981 Jun;13(2):1439-43. No abstract available.

PMID:
6972644
36.

The behavior of H-Y-incompatible neonatal skin grafts in rats.

Silvers WK, Collins NH.

Transplantation. 1979 Jul;28(1):57-9.

PMID:
377596
37.

Transplantation immunogenetics and MLC reactivities of partially inbred strains of salamanders (A. mexicanum): prelimanary studies.

DeLanney LE, Collins NH, Cohen N, Reid R.

Adv Exp Med Biol. 1975;64:315-24. No abstract available.

PMID:
1106148
38.

In vitro responses of urodele lymphoid cells: mitogenic and mixed lymphocyte culture reactivities.

Collins NH, Manickavel V, Cohen N.

Adv Exp Med Biol. 1975;64:305-14. No abstract available.

PMID:
1106147
39.

Mitogens as probes of lymphocyte heterogeneity in anuran amphibians.

Goldstine SN, Collins NH, Cohen N.

Adv Exp Med Biol. 1975;64:343-51. No abstract available.

PMID:
1081821

Supplemental Content

Loading ...
Support Center